Institute for Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $804K | Buy |
9,698
+22
| +0.2% | +$1.82K | 0.09% | 236 |
|
|
2025
Q1 | $785K | Buy |
9,676
+186
| +2% | +$15.1K | 0.1% | 226 |
|
|
2024
Q4 | $855K | Buy |
9,490
+441
| +5% | +$39.7K | 0.11% | 199 |
|
|
2024
Q3 | $894K | Buy |
9,049
+325
| +4% | +$32.1K | 0.11% | 199 |
|
|
2024
Q2 | $809K | Buy |
8,724
+90
| +1% | +$8.34K | 0.11% | 199 |
|
|
2024
Q1 | $819K | Buy |
8,634
+85
| +1% | +$8.07K | 0.11% | 196 |
|
|
2023
Q4 | $763K | Buy |
8,549
+436
| +5% | +$38.9K | 0.12% | 192 |
|
|
2023
Q3 | $592K | Sell |
8,113
-25
| -0.3% | -$1.83K | 0.11% | 223 |
|
|
2023
Q2 | $677K | Buy |
8,138
+127
| +2% | +$10.6K | 0.11% | 201 |
|
|
2023
Q1 | $611K | Sell |
8,011
-1,889
| -19% | -$144K | 0.12% | 222 |
|
|
2022
Q4 | $822K | Buy |
9,900
+898
| +10% | +$74.5K | 0.17% | 158 |
|
|
2022
Q3 | $714K | Buy |
9,002
+253
| +3% | +$20.1K | 0.16% | 170 |
|
|
2022
Q2 | $650K | Buy |
8,749
+2,968
| +51% | +$221K | 0.13% | 196 |
|
|
2022
Q1 | $520K | Buy |
+5,781
| New | +$520K | 0.08% | 285 |
|
|
2020
Q1 | – | Sell |
-160
| Closed | -$15K | – | 678 |
|
|
2019
Q4 | $15K | Buy |
+160
| New | +$15K | ﹤0.01% | 579 |
|
|
2019
Q2 | – | Sell |
-2,263
| Closed | -$205K | – | 495 |
|
|
2019
Q1 | $205K | Buy |
+2,263
| New | +$205K | 0.04% | 412 |
|
|
2017
Q3 | – | Sell |
-2,829
| Closed | -$218K | – | 395 |
|
|
2017
Q2 | $218K | Buy |
+2,829
| New | +$218K | 0.06% | 365 |
|